VIR 241220 7.50P (VIR241220P7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

VIR241220P7500

Watchlist

0.90
0.000.00%

15min DelayTrading Nov 21 15:56 ET

0.00High0.00Low

Intraday

5D
Daily

News

Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference
BusinesswireNov 25 09:30 ET
Trump Nominates Marty Makary For FDA Commissioner
Barron'sNov 22 22:27 ET
J.P. Morgan Sticks to Their Hold Rating for Vir Biotechnology (VIR)
TipRanksNov 21 07:06 ET · Ratings
Leerink Partners Maintains Vir Biotechnology(VIR.US) With Buy Rating, Maintains Target Price $18
Moomoo NewsNov 21 01:31 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
BenzingaNov 20 10:01 ET
TD Cowen Maintains Vir Biotechnology(VIR.US) With Buy Rating
Moomoo NewsNov 20 09:32 ET · Ratings

Comments

NoNo444

Nov 18 21:10

$Vir Biotechnology (VIR.US)$ The graph looks funny...

Jaguar8

Nov 18 21:06

ADDED NEWS

$Vir Biotechnology (VIR.US)$
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran

Stock_Drift

Nov 18 20:25

$Vir Biotechnology (VIR.US)$

Trytosaveabit

Nov 18 15:07

Update

$Vir Biotechnology (VIR.US)$ Reuters· just
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency

Stock_Drift

Nov 15 10:27

$Vir Biotechnology (VIR.US)$